AS
Abhijatya Singh
About Abhijatya Singh
Data last updated:
Abhijatya Singh is a Director at Limpid Pharma Private Limited (since 2018). The companies operate in Trading. Earlier, Abhijatya Singh was a Managing Director at Mejor Technologies Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Limpid Pharma Private Limited U51909HR2018PTC072827 | Director | 01 Mar 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Mejor Technologies Private Limited U72200DL2013PTC249557 | Managing Director | 20 Mar 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Abhijatya Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amandeep Singh Kalsi | 07946774 | Limpid Pharma Private Limited | Director |
| Ramesh Kumar | 08081751 | Limpid Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhijatya Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhijatya Singh
Abhijatya Singh currently holds 1 directorship: Limpid Pharma Private Limited (Director, since 01 Mar 2018).
Abhijatya Singh was first appointed on 20 Mar 2013 as Managing Director at Mejor Technologies Private Limited. The most recent appointment on record is 01 Mar 2018 at Limpid Pharma Private Limited.
Abhijatya Singh held 1 earlier board appointment: Mejor Technologies Private Limited (Managing Director, from 20 Mar 2013).
The current boards of Abhijatya Singh's companies include Amandeep Singh Kalsi (Limpid Pharma Private Limited), Ramesh Kumar (Limpid Pharma Private Limited).